E

Eyenovia
D

EYEN

1.70000
USD
-0.01
(-0.58%)
مغلق
حجم التداول
2,749
الربح لكل سهم
-16
العائد الربحي
-
P/E
-0
حجم السوق
3,559,375
أصول ذات صلة
    IDEXUSD
    IDEXUSD
    0.007635
    (14.01%)
    0.054480 USD
    IDEXBUSD
    IDEXBUSD
    -0.000535
    (-1.08%)
    0.048810 USD
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    N
    NIO
    0.07500
    (1.72%)
    4.44500 USD
    S
    SNDL
    0.00500
    (0.28%)
    1.77000 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    المزيد
الأخبار المقالات

العنوان: Eyenovia Inc

القطاع: Healthcare
الصناعة: Biotechnology
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.